Just Healthcare

Just Healthcare

Share this post

Just Healthcare
Just Healthcare
Emerging Psilocybin Therapy for End-of-Life Distress
Copy link
Facebook
Email
Notes
More

Emerging Psilocybin Therapy for End-of-Life Distress

Insights into a new study exploring risks, benefits, and applications for advanced cancer patients

Naveen Sankar S's avatar
Naveen Sankar S
Mar 07, 2025
∙ Paid
3

Share this post

Just Healthcare
Just Healthcare
Emerging Psilocybin Therapy for End-of-Life Distress
Copy link
Facebook
Email
Notes
More
1
Share
A modern and professional medical illustration depicting psilocybin therapy for end-of-life distress in advanced cancer patients. The image features a warm and uplifting color palette with shades of orange, gold, and soft blues to evoke a sense of positivity and innovation. The central focus is a symbolic representation of psilocybin molecules interacting with the brain, depicted through glowing neural connections and a subtle overlay of abstract medical icons. In the background, a compassionate doctor is seen discussing treatment with a patient in a comforting, supportive clinical setting. The overall style is clean, modern, and approachable, with elements that enhance understanding of the topic, such as stylized neurons and molecular structures.

Topline

A recent human study highlights both the potential benefits and the notable risks of psilocybin and other hallucinogens in patients facing end-of-life psychological distress, especially among those with advanced cancer and existing comorbidities. While these substances show promise for improving mood and quality of life in carefully controlled cl…

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Just Healthcare
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More